Biotech · Private company
Sirtex Medical
Track this companyFree. Adds Sirtex Medical to your Dealase workspace and tells you when its record changes.
Clinical trials135 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Cisplatin-gemcitabinePhase 3 · Intrahepatic CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- FOLFOX6mPhase 3 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)Phase 3 · Intrahepatic CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SIR-Spheres microspheresPhase 3 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- 99mTc-Macro Albumin AggregateCarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Resin microspheres containing yttrium-90 (Y-90)Unresectable Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SIR-Spheres microspheresCarcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
- SIR-Spheres yttrium-90 microspheresColorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Systemic chemotherapy (FOLFOX)Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRCPHASE2 · RECRUITING · started Apr 7, 2025ClinicalTrials.gov NCT06555133 · fetched Nov 12, 2026
- Y-90 With Durvalumab/Gem/Cis in Intrahepatic CholangioPHASE2 · RECRUITING · started Feb 13, 2024ClinicalTrials.gov NCT05655949 · fetched Nov 12, 2026
- SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAAPHASE4 · COMPLETED · started Apr 25, 2023ClinicalTrials.gov NCT05848947 · fetched Nov 12, 2026
- SIRT With Tremelimumab and Durvalumab for Resectable HCCPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 21, 2023ClinicalTrials.gov NCT05701488 · fetched Nov 12, 2026
- Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver MetastasesPHASE1 · RECRUITING · started Nov 16, 2022ClinicalTrials.gov NCT05195710 · fetched Nov 12, 2026
- Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line TherapyPHASE2 · WITHDRAWN · started Aug 17, 2022ClinicalTrials.gov NCT05315687 · fetched Nov 12, 2026
- Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma PatientsNA · ACTIVE_NOT_RECRUITING · started May 28, 2021ClinicalTrials.gov NCT04736121 · fetched Nov 12, 2026
- SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic CholangiocarcinomaPHASE2_PHASE3 · TERMINATED · started Feb 14, 2017ClinicalTrials.gov NCT02807181 · fetched Nov 12, 2026
- Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver MetastasesPHASE1 · COMPLETED · started Jan 9, 2017ClinicalTrials.gov NCT02602327 · fetched Nov 12, 2026
- Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver MetastasesPHASE2 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02195011 · fetched Nov 12, 2026
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal CancerPHASE3 · COMPLETED · started May 1, 2013ClinicalTrials.gov NCT01721954 · fetched Nov 12, 2026
- SIR-Spheres® for the Treatment of Unresectable Hepatocellular CarcinomaNA · TERMINATED · started Jul 18, 2007ClinicalTrials.gov NCT00503867 · fetched Nov 12, 2026
- FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal CancerNA · COMPLETED · started Aug 1, 2006ClinicalTrials.gov NCT00724503 · fetched Nov 12, 2026